Albuminuria or CKD stage as best marker of CVD in diabetes? (original) (raw)

Chronic kidney disease

Nature Reviews Nephrology volume 8, pages 376–377 (2012)Cite this article

Subjects

Cardiovascular events in patients with diabetes and no history of cardiovascular disease (CVD) are associated with albuminuria rather than kidney disease stage, according to a recent study. Reducing albuminuria, therefore, seems to benefit patients with diabetes but the underlying question still remains—is albuminuria a marker or mediator of CVD?

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Subscribe to this journal

Receive 12 print issues and online access

$189.00 per year

only $15.75 per issue

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

References

  1. Tonelli, M. et al. Chronic kidney disease and mortality risk: a systematic review. J. Am. Soc. Nephrol. 17, 2034–2047 (2006).
    Article Google Scholar
  2. Hemmelgarn, B. R. et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 303, 423–429 (2010).
    Article CAS Google Scholar
  3. Gansevoort, R. T. et al. Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int. 80, 93–104 (2011).
    Article CAS Google Scholar
  4. Ninomiya, T. et al. Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J. Am. Soc. Nephrol. 20, 1813–1821 (2009).
    Article Google Scholar
  5. Drury, P. L. et al. Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetologia 54, 32–43 (2011).
    Article CAS Google Scholar
  6. Yokoyama, H. et al. Chronic kidney disease categories and renal–cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25). Diabetologia http://dx.doi.org/10.1007/s00125-012-2536-y.
  7. Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375, 2073–2081 (2010).
  8. Weir, M. R. Microalbuminuria and cardiovascular disease. Clin. J. Am. Soc. Nephrol. 2, 581–590 (2007).
    Article Google Scholar
  9. de Zeeuw, D. et al. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation 110, 921–927 (2004).
    Article CAS Google Scholar
  10. Yusuf, S. et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 342, 145–153 (2000).
    Article CAS Google Scholar

Download references

Author information

Authors and Affiliations

  1. Medical Department, University of Colorado, 12700 East 19th Avenue C281, Aurora, 80045, CO, USA
    Judith Blaine & Moshe Levi

Authors

  1. Judith Blaine
  2. Moshe Levi

Corresponding author

Correspondence toJudith Blaine.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

About this article

Cite this article

Blaine, J., Levi, M. Albuminuria or CKD stage as best marker of CVD in diabetes?.Nat Rev Nephrol 8, 376–377 (2012). https://doi.org/10.1038/nrneph.2012.110

Download citation

This article is cited by